Cresemba (isavuconazonium sulfate capsules) — Cigna
Fungal Infection (Systemic) in a Patient With Cancer and Neutropenia – Prophylaxis
Initial criteria
- Patient has cancer with neutropenia (e.g., myelodysplastic syndrome, acute myeloid leukemia, post-allogeneic hematopoietic cell transplant) AND requires prophylaxis against fungal infection
Approval duration
6 months